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Abstract  
Lacto-N-biose (LNB) and galacto-N-biose (GNB) are major building blocks of free 
oligosaccharides and glycan moieties of glyco-complexes present in human milk and 
gastrointestinal mucosa. We have previously characterized the phospho-β-
galactosidase GnbG from Lactobacillus casei that is involved in the metabolism of LNB 
and GNB. GnbG has been used here in transglycosylation reactions and it showed the 
production of LNB and GNB with N-acetylglucosamine and N-acetylgalactosamine as 
acceptors, respectively. The reaction kinetics demonstrated that GnbG can convert 69 
± 4% and 71 ± 1% of o-Nitrophenyl-β-D-galactopyranoside into LNB and GNB, 
respectively. Those reactions were performed in a semi-preparative scale and the 
synthesized disaccharides were purified. The maximum yield obtained for LNB was 
10.7 ± 0.2 g/l and for GNB was 10.8 ± 0.3 g/l. NMR spectroscopy confirmed the 
molecular structures of both carbohydrates and the absence of reaction byproducts, 
which also supports that GnbG is specific for β1,3-glycosidic linkages. The purified 
sugars were subsequently tested for their potential prebiotic properties using 
Lactobacillus species. The results showed that LNB and GNB were fermented by the 
tested strains of Lactobacillus casei, Lactobacillus rhamnosus (except L. rhamnosus 
strain ATCC 53103), Lactobacillus zeae, Lactobacillus gasseri and Lactobacillus 
johnsonii. DNA hybridization experiments suggested that the metabolism of those 
disaccharides in 9 out of 10 L. casei strains, all L. rhamnosus strains and all L. zeae 
strains tested relies upon a phospho-β-galactosidase homologous to GnbG. The 
results presented here support the putative role of human milk oligosaccharides for 
selective enrichment of beneficial intestinal microbiota in breast-fed infants. 
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Introduction 
 
Human milk contains a large number of oligosaccharides, either free or bound to 
proteins and lipids (Bode 2012; Garrido et al. 2013; Thurl et al. 2010), and their 
physiological role is mostly unknown. The human milk oligosaccharides (HMOs) are 
resistant to host gastrointestinal digestion and therefore, a significant proportion 
reaches the infant colon (Engfer et al. 2000), where they can be substrates for the 
resident microbiota. Indeed, in the last few years much evidence suggests for HMOs a 
potential prebiotic effect. Lacto-N-biose I (LNB; Gal-β1-3GlcNAc) is the main building 
block of type-1 HMOs and it has also been found as a free sugar in human milk 
(Balogh et al. 2015). This disaccharide is fermented in vitro by all the tested strains of 
Bifidobacterium bifidum, Bifidobacterium longum subsp. infantis, B. longum subsp. 
longum and Bifidobacterium breve, and by some strains of Bifidobacterium 
pseudocatenulatum, Bifidobacterium animalis subsp. animalis and Bifidobacterium 
pseudolongum (Xiao et al. 2010). Additionally, fermentation of LNB using stool samples 
from infants showed a significantly promoted growth of B. bifidum (Satoh et al. 2013). 
Other important disaccharide is galacto-N-biose (GNB; Gal-β1-3GalNAc), a common 
O-glycan chain, which is found in mucin glycoproteins that are present in the human 
milk and gastrointestinal tract. GNB is also a significant core structure in functional 
sugar chains, such as the T-antigen disaccharide and it is also an essential part of the 
carbohydrate moieties of glycosphingolipids (Liu and Newburg 2013; Moran et al. 2011; 
Roy and Baek 2002). Regarding the metabolism of LNB and GNB by Bifidobacterium 
species, it has been shown that B. bifidum secretes a lacto-N-biosidase enzyme that 
hydrolyzes lacto-N-tetraose (LNT) into LNB and lactose. The liberated LNB is then 
incorporated into the cells by an ABC transporter specific for this disaccharide and for 
GNB. LNB and GNB present in the cytoplasm are then phosphorolytically cleaved by a 
LNB/GNB phosphorylase into Galactose-1P and the respective N-acetylhexosamines 
(Wada et al. 2008). By contrast, B. longum subsp. infantis directly incorporates LNT in 
the cytoplasm and subsequently hydrolyzes it into galactose and lacto-N-triose by a 
specific β-1,3-galactosidase (Yoshida et al. 2012). 
In addition to Bibidobacterium, the other genus with many recognized probiotic 
strains is Lactobacillus (Hill et al. 2014; Turroni et al. 2014). Species of this group are 
common inhabitants of the human gastrointestinal tract and they are already found at 
early stages of life. Regarding this, strains of Lactobacillus casei, Lactobacillus gasseri 
and Lactobacillus rhamnosus are frequently isolated from breast-fed infant feces 
(Albesharat et al. 2011; Martin et al. 2007; Rubio et al. 2014). Positive probiotic effects 
of Lactobacillus species have been shown on immune system stimulation, atopic 
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disease and several types of diarrhea in children among others (Ashraf and Shah 
2014; Kalliomaki et al. 2003; Pedone et al. 2000; Rodriguez-Diaz and Monedero 2013; 
Szajewska et al. 2013). We have previously demonstrated that fucosyl-N-
acetylglucosamine disaccharides, that form part of HMOs and also part of glyco-
complexes from the mucosa, were fermented by strains of L. casei, L. rhamnosus, B. 
breve and B. pseudocatenulatum (Becerra et al. 2015), suggesting a potential prebiotic 
effect for those carbohydrates. Additionally, we have characterized in L. casei strain 
BL23 the gnb operon (gnbREFGBCDA) that is involved in the transport and catabolism 
of LNB and GNB (Bidart et al. 2014). Both disaccharides are transported and 
phosphorylated by a specific phosphoenolpyruvate:sugar phosphotransferase system, 
and then they are hydrolyzed into galactose-6P and the corresponding N-
acetylhexosamine by the phospho-β-galactosidase encoded by gnbG gene. These 
results and the above described metabolism of LNB and GNB by Bifidobacterium 
species support the utilization of both disaccharides as potential prebiotics. To 
completely determine the biological function of LNB and GNB as prebiotics, further 
investigation is needed, and consequently, synthesis of sufficient amounts of them 
would be necessary. Chemical synthesis of LNB, GNB and LNB-containing 
oligosaccharides such as Lewis a and b blood group antigens has long been 
performed, but it is a tedious and expensive process since it requires multiple 
protection and de-protection steps to achieve the desired selectivity (Lemieux and 
Driguez 1975; Wilstermann and Magnusson 1995). The enzymatic synthesis of HMOs 
is an alternative to chemical methods and it offers the advantage to form specific 
glycosidic linkages in the presence of other reactive functional groups. LNB and GNB 
have been previously synthetized by the transglycosylation activity of β-galactosidases 
(Fujimoto et al. 1998; Vetere et al. 2000) and by multi-enzymatic systems (Nishimoto 
and Kitaoka 2007b; Nishimoto and Kitaoka 2009; Yu et al. 2010). In the present work, 
we have utilized the phospho-β-galactosidase GnbG from L. casei BL23 (Bidart et al. 
2014) in transgalactosylation reactions with N-acetylglucosamine and N-
acetylgalactosamine as acceptors, and showed that it very efficiently synthesized LNB 
and GNB, respectively. Afterward, the reactions were performed in a semi-preparative 
scale and the produced disaccharides were purified and analyzed for their in vitro 
fermentation by Lactobacillus species.  
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Materials and Methods 
 
Transgalactosylation activity assay  
 
GnbG phospho-β-galactosidase (GH35 family) was expressed as His-tagged protein 
and purified as previously described (Bidart et al. 2014). Transgalactosilation activity of 
GnbG was analyzed in 100 mM Tris-HCl buffer, pH 7.5. The reactions mixtures 
contained o-nitrophenyl β-D-galactopyranoside (oNP-gal) 40 mM as donor and N-
acetylglucosamine (GlcNAc) 200 mM or N-acetylgalactosamine (GalNAc) 200 mM as 
acceptor. The mixtures were heated at 98ºC to overcome the poor solubility of oNP-gal 
and then cooled to the reaction temperature of 42ºC. The reactions were started by the 
addition of 0.17 U/ml of GnbG (one unit was defined as the amount of enzyme able to 
release one µmol of oNP in one min at 42ºC, pH 7.5 and with oNP-gal 5 mM). Samples 
were withdrawn at different times and immediately heated at 100ºC for 3 min to stop 
the reaction.  
Transgalactosylation reactions aimed at the purification of the produced 
disaccharides were performed in the conditions described above for 3 h and they were 
heat-treated to stop the reaction.  
 
Analytical and semi-preparative HPLC analysis 
 
The transgalactosylation reaction products were analyzed by high-performance liquid 
chromatography (HPLC) using a Jasco PU2080Plus system. This system was coupled 
to a refractive index detector (Jasco RI-2031 Plus) using an analytical Rezex RCM-
Monosaccharide column (Phenomenex, Torrance, CA, USA). The column was kept at 
80ºC and the samples were eluted in isocratic mode using water as the mobile phase 
at a flow rate of 0.6 ml/min. Di- and monosaccharides were confirmed by comparison of 
their retention times with those of standards (LNB, GNB, galactose, GlcNAc and 
GalNAc). LNB and GNB were obtained from Carbosynth Ltd (Compton, Berkshire, UK). 
Transgalactosylation reaction products were purified by HPLC using a preparative 
Rezex RCM-Monosaccharide column (Phenomenex, Torrance, CA, USA). The column 
was kept at 80ºC and the samples were eluted in isocratic mode using water as the 
mobile phase at a flow rate of 4 ml/min, and fractions of 1 ml were collected. 
Appropriate fractions were pooled, concentrated by rotary evaporator and analyzed by 
using the analytical Rezex RCM-Monosaccharide column in the conditions described 
above.  
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Nuclear magnetic resonance (NMR) spectroscopy 
 
Lyophilized samples were dissolved in 550 µl of deuterated water and analyzed 
immediately. NMR spectra were recorded at 27 °C using a Bruker Avance II 600 MHz 
spectrometer equipped with a 5-mm TCI cryoprobe. One-dimensional (1D) 1H spectra 
with presaturation and a noesy mixing period for water suppression and improved 
baseline were acquired with 256 transients. 1H- 13C heteronuclear single quantum 
coherence (HSQC) experiments were acquired with 200 transients over a spectral 
width of 3.5 (for 1H) and 30 ppm (for 13C) and 128 points in the indirect dimension. Total 
correlation spectroscopy (TOCSY) experiments were acquired with 32 transients over a 
spectral width of 3.5 ppm in both dimensions and 128 points in the indirect dimension. 
NMR spectra were processed using the program Topspin3.2 (Bruker Biospin).  
 
Microorganisms and culture media  
 
The Lactobacillus strains used in this study are listed in Table I. They were routinely 
grown at 37ºC under static conditions in MRS medium (Difco, Sparks, MD, USA). The 
recombinant Escherichia coli strain PE159 that express the phospho-β-galactosidase 
GnbG (Bidart et al. 2014) was grown in Luria-Bertani (LB) medium (Pronadisa, Madrid, 
Spain) with ampicillin (100 µg/ml) at 37ºC under vigorous shaking. The corresponding 
solid media were prepared by adding 1.8 % agar. 
 
Culture of Lactobacillus strains with lacto-N-biose (LNB) and galacto-N-biose (GNB) 
 
The Lactobacillus strains were grown overnight at 37ºC under static conditions in 
sugar-free MRS basal medium containing: bactopeptone (Difco, Sparks, MD, USA), 10 
g/l; yeast extract (Pronadisa, Madrid, Spain), 4 g/l; sodium acetate, 5 g/l; tri-ammonium 
citrate, 2 g/l; magnesium sulphate 7-hydrate, 0.2 g/l; manganese sulphate 
monohydrate, 0.05 g/l; and Tween 80, 1 ml/l. Overnight cultures were diluted to an 
OD550 of 0.1 in 100 µl of MRS basal medium containing 4 mM of purified LNB or GNB. 
Bacterial growth was monitored up to 30 h or 70 h by spectrophotometric 
measurements every 30 min at 550 nm in 96-well plates at 37ºC without shaking in a 
POLARstar Omega microplate reader (BMG Labtech, Offenburg, Germany). At least 
three independent biological replicates for each growth curve were obtained. Results 
were expressed as means ± standard deviations.  
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Disaccharide analysis in culture supernatants  
 
To determine the carbohydrates present in the supernatants from the Lactobacillus 
strain cultures, the cells were removed by centrifugation and the cultures were 
analyzed by HPLC using a Jasco PU2080Plus system and an analytical Rezex RCM-
Monosaccharide column in the conditions described above. LNB and GNB were 
confirmed by comparison of their retention times with those of standards. 
 
Southern blot analysis 
 
Total DNA was isolated from Lactobacillus strains using the REALPURE “SSS” 
genomic DNA extraction kit (Durviz, Paterna, Spain). DNA probes were synthesized by 
PCR using L. casei BL23 chromosomal DNA as template, deoxynucleoside 
triphosphate mix from the Roche PCR digoxigenin-labeling mix and Taq DNA 
polymerase (Expand High Fidelity PCR system, Roche, Mannheim, Germany). The 
gnbG probe was amplified with primers: LNB5Fow (5’-TCG ATC GAT CAT GAG TTT 
ATG-3’) and LNB5Rev (5’-TGC CTC ATC GCT GGC TTG-3’). Chromosomal DNA from 
the Lactobacillus strains was digested with the restriction enzyme EcoRV. The cleaved 
DNAs were separated in a 0.8% agarose gel and transferred to a nylon membrane as 
previously described (Sambrook et al. 1989). Hybridization, washing and staining were 
performed as recommended by the supplier using the CDP-Star chemiluminescent 
substrate (Roche, Mannheim, Germany). 
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Results  
 
Transglycosylation activity of the phospho-β-galactosidase GnbG  
 
The phospho-β-galactosidase GnbG from Lactobacillus casei BL23 has been 
previously characterized showing that this enzyme is able to hydrolyze lacto-N-biose 
(LNB) and galacto-N-biose (GNB) (Bidart et al. 2014). These substrate specificities 
conducted us in this work to examine the feasibility of using GnbG to synthesize those 
disaccharides. We tested the transgalactosylation activity of the 6x(His)GnbG with N-
acetyl-glucosamine (GlcNAc) or N-acetyl-galactosamine (GalNAc) as acceptor and o-
Nitrophenyl-β-D-galactopyranoside (o-NPG) as donor. HPLC analyses suggested that 
oligosaccharides were being synthesized in each transglycosylation reaction whose 
retention time coincided with that of LNB and GNB standards, respectively (Fig S1).  To 
analyze the transglycosylation kinetics of GnbG, a time course reaction was performed 
and the synthesis of LNB and GNB with GlcNAc and GalNAc as acceptor, respectively, 
were determined (Fig. 1). The maximum transient yields of 69 ± 4 % for LNB and 71 ± 
1 % for GNB with respect to the added o-NPG were obtained after 3 h, respectively.  
 
Preparative scale synthesis, purification and characterization of lacto-N-biose (LNB) 
and galacto-N-biose (GNB).  
 
The transglycosylation reactions described above for GnbG were scaled from µl to ml 
in the conditions described in the material and methods section. Both reactions using 
GlcNAc and GalNAc as acceptor, respectively, were independently loaded in a semi-
preparative scale ion-exclusion chromatography and the fractions containing LNB and 
GNB were collected (Fig. S1). The maximum yields obtained of LNB and GNB were 
10.7 ± 0.2 g/l and 10.8 ± 0.3 g/l., respectively. The purified LNB and GNB were 
characterized by NMR spectroscopy and compared with the commercial disaccharides. 
Analysis of the corresponding 1D 1H and the 2D 1H-13C HSQC spectra (Fig. 2 and 3) 
revealed identical 1H and 13C chemical shift values for purified and commercial LNB 
and GNB. In addition, the acquisition of 2D TOCSY experiments (Fig. S2) showed 
exactly the same spin coupling patterns for the synthetized compounds and the 
standard samples, and it also showed the lack of any additional signals in the spectra 
of the purified compounds. These results demonstrated the absence of reaction 
byproducts in the purified samples and confirmed the glycosidic linkage specificity for 
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both disaccharides. This further indicates that the phospho-β-galactosidase GnbG is 
specificity for β1,3-linkages production. 
 
In vitro fermentation of lacto-N-biose (LNB) and galacto-N-biose (GNB) by 
Lactobacillus strains. 
 
The utilization of LNB and GNB by Bifidobacterium species has been previously 
reported (Nishimoto and Kitaoka 2007a; Satoh et al. 2013; Xiao et al. 2010). However, 
the fermentation of these disaccharides by Lactobacillus, a genus with also many 
probiotics strains, has not been tested. Therefore, in order to analyze the capacity of 
several species of this genus (Table 1) to metabolize LNB and GNB, the growth pattern 
in MRS basal medium supplemented with these disaccharides synthesized here was 
determined. No growth was observed in the presence of LNB and GNB for the tested 
strains of Lactobacillus plantarum, Lactobacillus curvatus, Lactobacillus acidophilus, 
Lactobacillus delbruckii subsp. bulgaricus, Lactobacillus pentosus, Lactobacillus 
salivarius, Lactobacillus intestinalis and Lactobacillus taiwanensis (data not shown). In 
contrast, utilization of LNB and GNB was evidenced in strains of L. casei, L. 
rhamnosus, Lactobacillus zeae, L. gasseri and Lactobacillus johnsonii. All the tested 
strains of L. casei were able to grow on LNB and GNB as carbon source (Fig. 4), 
including strain BL23, whose capacity to ferment both sugars has been recently 
demonstrated in our lab and it was used here as a positive control (Bidart et al. 2014). 
Utilization of LNB and GNB was also evidenced in 5 out of 6 strains of L.  rhamnosus 
(Fig. 5). No growth difference was observed for L.  rhamnosus strain BL377 (the widely 
marketed L. rhamnosus GG strain) in the presence of these disaccharides with respect 
to the culture control without carbohydrate source. Sugar content analysis of the culture 
supernatants detected LNB and GNB, respectively, in the supernatants from strain 
BL377, while they were consumed by the rest of the strains tested from L. casei and L. 
rhamnosus species. 
The L. zeae (strains BL95 and BL257), L. gasseri (strain BL277) and L. johnsonii 
(strains BL261, BL281 and BL287) tested here were also able to grow with LNB and 
GNB (Fig. 6). Sugar content analysis of the culture supernatants of these strains 
showed that LNB and GNB were consumed. Curiously, L. gasseri and L. johnsonii 
species, which are phylogenetically close (Zhang et al. 2011), presented similar growth 
patterns, showing an autolytic phenotype. The cell lysis might be due to induction of the 
already characterized prophages in L. gasseri (Baugher et al. 2014; Ismail et al. 2009) 
and L. johnsonii (Denou et al. 2008; Ventura et al. 2003). As occurs in the majority of 
the tested lactobacilli, the L. johnsonii strains grew better in GNB than in LNB. In this 
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later sugar, the cells began exponential growth only after 20 (strain BL287) or 40 h 
(strains BL261 and BL281), suggesting a low induction of the metabolic genes by LNB 
or the involvement of different metabolic routes for LNB and GNB.  
 
 
Presence of genes homologous to gnbG in Lactobacillus strains 
 
We have previously shown that the ability of L. casei strain BL23 to grow in the 
presence of LNB and GNB is dependent upon the activity of the phospho-β-
galactosidase GnbG encoded by gnbG gene (Bidart et al. 2014). To find out if the 
above Lactobacillus strains that ferment LNB and GNB also contain an homologous 
gnbG gene, Southern blot analysis was performed (Fig. 7). The results demonstrated 
that the L. casei strains (BL28, BL32, BL82, BL83, BL86, BL87, BL91 and BL93), L. 
rhamnosus strains (BL1, BL2, BL3, BL327 and BL358) and L. zeae strains (BL95 and 
BL257) that grow with LNB and GNB as carbon sources presented hybridization 
signals, suggesting that in these strains, the metabolism of those disaccharides also 
relies on a phospho-β-galactosidase homologous to GnbG. The only exception would 
be L. rhamnosus strain BL377 that as mentioned below may carry a non-functional gnb 
operon. L. casei strain BL94 (ATCC 393) (Fig. 4), L. gasseri and L. johnsonii species 
(Fig. 6) can be cultured in the presence of LNB or GNB but, in agreement with the lack 
of gnbG homologues in their genomes as described below, no hybridization bands 
were present (Fig. 7), indicating that the hydrolysis of these carbohydrates must 
depend on a different glycosidase.  
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Discussion 
Many studies suggest that HMOs play important roles in infant health (Bode et al., 
2012), however, the low availability of these oligosaccharides limits the research about 
their functionality and their eventual application. In the present work, we have utilized 
the phospho-β-galactosidase GnbG from L. casei BL23 (Bidart et al. 2014) in 
transgalactosylation reactions directed to synthesize LNB and GNB. These are major 
building blocks of oligosaccharides present in human milk and gastrointestinal mucosa. 
The transgalactosylation efficiency of GnbG is remarkably high compared with the 
efficiency of other glycosidases, which usually is moderately ranged from 20 to 40% 
(Schmaltz et al. 2011; Trincone 2015). Indeed, LNB and GNB have been previously 
synthesized in transglycosylation reactions with the β-galactosidase BgaC from 
Bacillus circulans, but with low yields (12.2 and 10.1% for LNB and GNB, respectively) 
(Fujimoto et al. 1998). Although both enzymes, GnbG and BgaC belong to the 
glycoside hydrolase family 35, they only showed a 41% sequence identity, which might 
explain the strong difference in the transgalactosylation efficiency between both 
enzymes. LNB has also been produced by the transglycosylation activity of a β-
galactosidase isolated from the plant pathogen Xanthomonas manihotis (Vetere et al. 
2000). This enzyme was shown to produce LNB at a maximum yield of 55 % after 20 h 
reaction. Therefore, GnbG displayed the highest transglycosylation rate for the 
synthesis of LNB and GNB reported to date. Both disaccharides have also been 
synthesized using a mix of four (sucrose phosphorylase, lacto-N-biose phosphorylase, 
UDP-hexose 1-P and UDP-glucose 4-epimerase) (Nishimoto and Kitaoka 2007b; 
Nishimoto and Kitaoka 2009) or two enzymes (galactose-1P kinase and lacto-N-biose 
phosphorylase) (Yu et al. 2010) resulting in a high efficiency of synthesis.  
Knowledge about the fermentation of LNB and GNB is almost limited to 
Bifidobacterium species (Satoh et al. 2013; Xiao et al. 2010). Here we have shown that 
all L. casei strains and all but one L. rhamnosus strains tested were able to grow in the 
presence of both disaccharides. These results are in agreement with the fact that more 
than 80% of the available genomes of the Lactobacillus casei/paracasei/rhamnosus 
group contain the gnb gene cluster involved in the transport and catabolism of both 
sugars (Bidart et al. 2014). L. rhamnosus strain BL377 has a complete gnb operon 
(GenBank genome accession number FM179322), however, it did not ferment LNB 
and GNB (Fig. 5). An analysis of the gnb cluster in this strain showed an extra open 
reading frame (ORF), encoding a putative protein of 82 amino acids that overlaps with 
the 3’ end of the gnbG gene. The transcription and/or translation of that ORF might 
affect the proper transcription and/or translation of the downstream gnb genes, which 
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would result in the impairment of strain BL377 to transport and hydrolyze LNB and 
GNB. Two strains of L. zeae, a species which is phylogenetically close to the L. 
casei/paracasei/rhamnosus group (Vasquez et al. 2005), were also able to grow in the 
presence of LNB and GNB (Fig. 6). Analysis of the available genome sequence of L. 
zeae strain BL95 (GenBank accession number BACQ00000000) showed the presence 
of a complete gnb operon, encoding proteins which deduced amino acid sequences 
ranging from 86% to 93% identity respect to the L. casei BL23 gnb gene products 
(Bidart et al. 2014). Contrarily, L. casei strain BL94 (ATCC 393) can be cultured in the 
presence of LNB or GNB (Fig. 4) but lacks gnbG homologues in its genome (GenBank 
accession number AZCO00000000). Similarly, the L. gasseri and L. johnsonii strains 
tested here were able to ferment both disaccharides but do not contain a gnb cluster. 
BLAST search using the amino acid sequence of phospho-β-galactosidase GnbG from 
L. casei BL23 (Bidart et al. 2014) against the translated genomes of L. gasseri BL277 
(ATCC 33323) (Azcarate-Peril et al. 2008) and L. johnsonii BL287 (DSM 10533) (Sun 
et al. 2015), did not show relevant homology with any protein, suggesting the absence 
of an enzyme homologous to GnbG in those strains. This is in agreement with the DNA 
hybridization analysis showed above. Therefore, the hydrolysis of both disaccharides 
must rely upon other glycosidases. Indeed, the L. gasseri BL277 genome encodes 20 
putative glycosidases (Azcarate-Peril et al. 2008), including several phospho-β-
glycosidases (Honda et al. 2012; Nagaoka et al. 2008). As well, the L. johnsonii BL287 
genome also encodes more than 20 putative glycosidases (Sun et al. 2015). However, 
the specificity of these enzymes is not known. Growth patterns, genome inspection and 
hybridization with the gnbG probe demonstrated that LNB and GNB utilization is a 
widespread feature in Lactobacillus casei/paracasei/rhamnosus/zeae. This is a group 
of species linked to the gastrointestinal habitat for which genes for the utilization of 
other important human milk and mucosal oligosaccharides have been described 
(Rodriguez-Diaz et al. 2012), highlighting the role of the utilization of this substrates in 
the development in this particular niche. Whether L. gasseri, L. johnsonii and the L. 
casei ATCC393 strain rely on systems similar to the bifidobacteria for LNB and GNB 
catabolism, or they express new glycosidases with LNB and GNB specificities remains 
to be investigated. 
In this work we have shown that the phospho-β-galactosidase GnbG isolated from L. 
casei BL23 can be used in transglycosylation reactions directed to synthesize LNB and 
GNB, which are important disaccharides present in human milk, either free or forming 
part of the structure of oligosaccharides and glycoproteins. The reactions were 
efficiently scaled and the produced LNB and GNB easily purified. The prebiotic 
potential of these carbohydrates for enhancement of specific Bifidobacterium species, 
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as shown previously, and Lactobacillus species, as shown here, support the putative 
role of human milk oligosaccharides for selective stimulation of the growth of beneficial 
gastrointestinal microbiota in breast-fed infants. Furthermore, GnbG might be used in 
transglycosylation reactions to produce derivative compounds, such as glycosides of 
LNB and GNB.  
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Table 1. List of Lactobacillus strains used in this study 
Species Straina Culture collectionb 
Lactobacillus rhamnosus BL1 CECT 278 
Lactobacillus rhamnosus BL2 CECT 276 
Lactobacillus rhamnosus BL3 CECT 275 
Lactobacillus plantarum BL8 CECT 748 
Lactobacillus curvatus BL14 CECT 904 
Lactobacillus acidophilus BL17 CECT 903 
Lactobacillus casei BL23 CECT 5275 
Lactobacillus casei BL28 64 H 
Lactobacillus casei BL32 CECT 4040 
Lactobacillus delbruckii 
b  b l i  
BL33 CECT 4005 
Lactobacillus pentosus BL35 CECT 4023 
Lactobacillus casei BL82 CECT 277 
Lactobacillus casei BL83 CECT 4043 
Lactobacillus casei BL86 CECT 4045 
Lactobacillus casei BL87 ATCC 11578 
Lactobacillus casei BL91 CECT 4646 
Lactobacillus casei BL93 61 BG 
Lactobacillus casei BL94 ATCC 393 
Lactobacillus zeae BL95 ATCC 15820 
Lactobacillus salivarius BL158 CECT 4063 
Lactobacillus johnsonii BL261 AD99 
Lactobacillus plantarum BL166 NCIMB 8826 
Lactobacillus zeae BL257 IFI-CA 
Lactobacillus gasseri BL277 ATCC33323 
Lactobacillus acidophilus BL280 CECT 4179 
Lactobacillus johnsonii BL281 CECT 289 
Lactobacillus johnsonii BL287 DSM 10533 
Lactobacillus intestinalis  BL288 DSM 6629 
Lactobacillus rhamnosus BL327 CECT 288 
Lactobacillus taiwanensis BL340 DSM 21041 
Lactobacillus rhamnosus BL358 HN001 
Lactobacillus rhamnosus BL377 ATCC 53103 
aBL, Culture Collection from our laboratory. 
bCECT, Spanish Type Culture Collection; ATCC, American Type Culture Collection; 
DSM, Deutsche Sammlung von Mikroorganismen; NCIMB, National Collection of 
Industrial, Food and Marine Bacteria, UK; L. casei strains 64 H y 61 BG are described 
in (Gasser and Mandel 1968); L. rhamnosus HN001, also known as DR20, is described 
in (Prasad et al. 1998); L. zeae BL257 was isolated from biological ageing wine 
(Moreno-Arribas and Polo 2008). L. johnsonii BL261 was isolated from rat intestinal 
content (Sarmiento-Rubiano et al. 2007). 
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Figure legends 
 
Figure 1. Time-dependent synthesis of lacto-N-biose (close symbols) and galacto-N-
biose (open symbols) by transglycosylation catalyzed by the phospho-β-galactosidase 
GnbG from Lactobacillus casei. Yield is expressed as a percentage of the donor 
concentration (o-nitrophenyl-β-D-galactopyranoside 40 mM).  
 
Figure 2. 1H 1D and 2D heteronuclear single quantum coherence (HSQC) NMR 
spectra acquired at 600 MHz and 27 °C 1H- 13C of a) purified lacto-N-biose and b) 
commercial lacto-N-biose.  
 
Figure 3. 1H 1D and 2D heteronuclear single quantum coherence (HSQC) NMR 
spectra acquired at 600 MHz and 27 °C 1H- 13C of a) purified galacto-N-biose and b) 
commercial galacto-N-biose.  
 
Figure 4. Growth curves of Lactobacillus casei strains BL23, BL28, BL32, BL82, BL83, 
BL86, BL87, BL91, BL93 and BL94 in MRS basal medium without added carbon 
source (triangles), with lacto-N-biose (squares) or galacto-N-biose (circles) as the only 
carbon source. Data presented are mean values based on at least three replicates. 
Error bars indicate standard deviations. 
 
Figure 5. Growth curves of Lactobacillus rhamnosus strains BL1, BL2, BL3, BL327, 
BL358 and BL377 in MRS basal medium without added carbon source (triangles), with 
lacto-N-biose (squares) or galacto-N-biose (circles) as the only carbon source. Data 
presented are mean values based on at least three replicates. Error bars indicate 
standard deviations. 
 
Figure 6. Growth curves of Lactobacillus zeae strains BL95 and BL257, Lactobacillus 
gasseri strain BL277 and Lactobacillus johnsonii strains BL261, BL281 and BL287 in 
MRS basal medium without added carbon source (triangles), with lacto-N-biose 
(squares) or galacto-N-biose (circles) as the only carbon source. Data presented are 
mean values based on at least three replicates. Error bars indicate standard deviations. 
 
Figure 7. Southern blot analysis of the EcoRV-digested genomic DNA from 
Lactobacillus rhamnosus strains (BL1, BL2, BL3, BL327, BL358, BL377), Lactobacillus 
casei strains (BL23, BL28, BL32, BL82, BL83, BL86, BL87, BL91, BL93, BL94), 
Lactobacillus zeae strains (BL95 and BL257), Lactobacillus gasseri strain (BL277) and 
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Lactobacillus johnsonii strains (BL261, BL281 and BL287). A DNA fragment 
corresponding to gnbG from Lactobacillus casei strain BL23 was used as a probe. 
Genomic DNA from this strain was used as positive control. The numbers on the left 
indicate the size in kb of the DNA fragments from BL23 strain. 
 
Supplemental figures 
Figure S1. HPLC chromatogram of the transglycosylation reaction products with the 
phospho-β-galactosidase GnbG and N-acetylglucosamine (a) or N-
acetylgalactosamine (c) as acceptor; HPLC chromatogram of the pooled fractions from 
the semi-preparative scale ion-exclusion chromatography containing the purified lacto-
N-biose (b) or galacto-N-biose (d). 1. Tris-HCl; 2. Lacto-N-biose; 3. N-
Acetylglucosamine; 4. Glycerol; 5. o-nitrophenyl-β-D-galactopyranoside; 6. galacto-N-
biose; 7. N-acetylgalactosamine.  
 
Figure S2. 2D total correlation spectroscopy (TOCSY) NMR spectra acquired at 600 
MHz and 27 °C 1H- 13C of a) purified lacto-N-biose, b) commercial lacto-N-biose, c) 
purified galacto-N-biose, d) commercial galacto-N-biose. 
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